Xavier Moisset

72PUBLICATIONS
216CO-AUTHORS
Medical infection agents (incl. prions)Gene and molecular therapyMedical microbiology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Autonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (72)

|Sep 30, 2026
Air pollution and the risk of multiple sclerosis relapses in the Paris region, the CONFISEP study.

|Sep 26, 2026
Serum GFAP and Age Accurately Distinguish AQP4-IgG Positive and Double Seronegative NMOSD From MOGAD After a Recent Attack.

|Aug 14, 2026
Comparative effectiveness of ofatumumab and ocrelizumab in relapsing multiple sclerosis: a target trial emulation using multinational registry data.

|Aug 04, 2026
Borrelia miyamotoi meningoradiculitis complicating ocrelizumab treatment for multiple sclerosis: A report of three cases.

|Jun 02, 2026
A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

|May 22, 2026
French NOMADMUS Cohort Overview: Landscape Evolution of AQP4+NMOSD and MOGAD From 2010 to 2024.

Pageof 12

Frequent Collaborators

25 joint publications

Jonathan Ciron

19 joint publications

Sandra Vukusic

19 joint publications

Eric Thouvenot

18 joint publications

Romain Marignier